Roth Capital initiated coverage on IRadimed Corp (NASDAQ: IRMD) with a Buy rating and a price target of $14.00.

For an analyst ratings summary and ratings history on IRadimed Corp click here. For more ratings news on IRadimed Corp click here.

Shares of IRadimed Corp closed at $11.03 yesterday.